HACE1 and cancer: Since HACE1 is the target of epigenetic inactivation in Wilms’ tumor and has been proposed as a tumor suppressor gene in multiple human cancers, it is tempting to speculate that HACE1 might be involved in the pathogenesis of NKTCL (Huang et al., 2010).